Q4 Follow-Up - Pharmarise HDS (2796 JP) - September 2, 2025
In Q4 of FY2025/5, Pharmarise Holdings Corporation (hereafter, the Company) consolidated the performance of next PH Corporation (hereafter, next...
240 Views
Pharmarise HDS (2796 JP) - Navigating Industry Restructuring...
Japan’s elderly population is projected to continue to grow through 2040, and Pharmarise HDS will benefit from the corresponding increase in the...
502 Views
Cocokara (3098) Going With MatsuKiyo (3088) But Ratio Overextended
A couple of minutes before the AM session close yesterday, the Nikkei Inc released a story saying that the Special Committee formed to help...
750 Views
No more insights